Current Report No. 9/2023
Date: 27.03.2023 r.
Legal basis: Article 19(3) of the MAR Regulation – information on transactions performed by persons discharging managerial responsibilities
The Management Board of Medicalgorithmics S.A. (the “Company“) informs, pursuant to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (“MAR Regulation“), that on 27 March 2023 the Company received from persons discharging managerial responsibilities: Mr. Jarosław Jerzakowski – Member of the Management Board, Mr. Maciej Gamrot – Member of the Management Board for Finance and Mr. Przemysław Tadla – Member of the Management Board, notifications of purchasing in total 9.193 Company’s shares on the Warsaw Stock Exchange market, as referred to in Article 19 Section 1 of the MAR Regulation.
According to the notifications received by the Company:
- Mr. Jarosław Jerzakowski – Member of the Management Board of the Company acquired in total 3,014 Company shares,
- Mr. Maciej Gamrot – Member of the Management Board for Finance acquired in total 3,175 Company shares,
- Mr. Przemysław Tadla – Member of the Management Board of the Company acquired in total 3,004 Company shares.
The notifications are attached to this report.
Attachments:
Notification of a transaction pursuant to Article 19 of the MAR Regulation – J. Jerzakowski
Notification of a transaction pursuant to Article 19 of the MAR Regulation – M. Gamrot
Notification of a transaction pursuant to Article 19 of the MAR Regulation – P. Tadla